The Rx and Illicit Drug Summit is no longer accepting abstracts for the 2026 agenda.

Abstracts are subject to acceptance by the Advisory Board. Only abstracts received by the submission deadline will be considered.

Abstracts will be accepted in the following categories: 

• ADVOCACY
• CLINICAL
• ILLICIT DRUGS
• TRENDING TOPICS
• PREVENTION
• PUBLIC SAFETY
• RECOVERY SUPPORTS